scispace - formally typeset
P

Philip A. Poole-Wilson

Researcher at National Institutes of Health

Publications -  443
Citations -  69648

Philip A. Poole-Wilson is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Heart disease. The author has an hindex of 105, co-authored 443 publications receiving 66861 citations. Previous affiliations of Philip A. Poole-Wilson include Harefield Hospital & St George's Hospital.

Papers
More filters
Journal ArticleDOI

Syndrome X in women is associated with oestrogen deficiency

TL;DR: The findings confirm that the majority of patients with syndrome X are women in whom the chest pain began after the onset of menopause, and Ovarian hormone deficiency may, therefore, play a role inThe onset of syndrome X in female patients.
Journal ArticleDOI

Role of Cardiovascular Magnetic Resonance as a Gatekeeper to Invasive Coronary Angiography in Patients Presenting With Heart Failure of Unknown Etiology

TL;DR: LGE-CMR is a safe, clinically effective, and potentially economical gatekeeper to CA in patients presenting with heart failure of uncertain etiology, and was found to be a cheaper diagnostic strategy in a decision tree model when United Kingdom–based costs were assumed.
Journal ArticleDOI

Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during cardiac catheterisation

TL;DR: Chez les malades atteints de «syndrome X» (douleurs precordiales de type angor mais arteres coronaires normales), les etudes avec catheterisme cardiaque peuvent montrer une sensibilite exageree a l'instrumentation.
Journal ArticleDOI

Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure

TL;DR: In this paper, the authors compared histological findings in limb and respiratory muscles from control subjects and patients with heart failure of two different aetiologies, and found that the histological abnormalities are more marked in the dilated cardiomyopathy than ischaemic group.